HPLC Market

Global HPLC Market Size (2023 to 2028)

The global market size for high-performance liquid chromatography is expected at around USD 4.02 Billion in 2023 and is expected to grow at a CAGR of 5.7% to reach USD 5.31 Billion by 2028.

Global HPLC Market Share Insights:

• Based on product, the instruments segment led the market and captured 42.5% of the global HPLC market share in 2022.
• Based on application, the clinical research segment dominated the market and held 36.4% of the global market share in 2022.
• North America had the biggest worldwide market share in 2022, which was 31.7%. 
• The European region accounted for a notable share of the global market in 2022. 

MARKET DRIVERS:

The growing demand for HPLC in pharmaceutical analysis majorly drives market growth. HPLC is a high-sensitivity technique and offers greater accuracy, due to which the adoption is growing significantly in the pharmaceutical industry. The essential role that HPLC plays in drug development, quality control, regulatory compliance, stability testing, and pharmacokinetic studies majorly drives the adoption of HPLC in the pharmaceutical industry. The growing usage of HPLC in life sciences and biotechnology for applications such as protein analysis, metabolomics, genomics, and drug discovery further boosts the growth rate of the HPLC market.

The ability of high-performance liquid chromatography to identify the drug, monitor diseases, and adopt hyphenated techniques further accelerates the market's growth rate. The growing R&D investments, increasing number of global contract research organizers and pharmaceutical industries contribute to the market growth. The growing importance of ensuring food safety and quality drives the adoption of HPLC in food analysis to detect contaminants, pesticide residues, and other quality parameters and propel market growth.

The growing usage of HPLC in environmental testing and monitoring including the analysis of pollutants, organic compounds, and water quality, stringent regulatory requirements and quality control standards in industries such as pharmaceuticals, food, and environmental testing and rapid adoption of HPLC in forensic science fuels the growth rate of the HPLC market. The growing number of improvements in the healthcare infrastructure in developing and developed countries is fuelling the demand for HPLC systems and services for clinical analysis and research and driving market growth. The growing number of investments in healthcare, pharmaceuticals, and research infrastructure in emerging markets, such as Asia Pacific and Latin America and the rising trend towards precision medicine and personalized therapies requires robust analytical techniques like HPLC for biomarker analysis, therapeutic drug monitoring, and pharmacokinetic studies support the growth of the HPLC market.

MARKET RESTRAINTS:

High costs associated with HPLC systems and associated accessories are one of the major factors hampering the market growth. The shortage of trained professionals who can effectively utilize and troubleshoot HPLC instruments, the availability of alternative analytical techniques available, such as gas chromatography (GC), mass spectrometry (MS), and capillary electrophoresis (CE) and stringent regulatory requirements further limit the growth rate of the HPLC market. The lack of appropriate infrastructure, such as a stable power supply, clean laboratory environment, and adequate space and slower adoption rates of HPLC due to various factors such as limited awareness, infrastructure challenges, and budget constraints further inhibit the growth rate of the HPLC market.

Impact of COVID-19 on the global HPLC Market:

COVID-19 was well known as the coronavirus globally. The WHO announced COVID-19 as a pandemic in March 2020. More than 200 countries have announced a strict lockdown guideline to curb the spread of the novel coronavirus disease. Due to the lockdown, all companies got shut down and saw huge losses during the pandemic. The High-Performance Liquid Chromatography market has faced many difficulties sustaining its growth. The break of the supply chain is the major drawback for the market. The insufficient funding to research and academic institutes and low demand for the product hinder the market. But a few key players in the market are trying their best to be in the market, such as Agilent Technologies, with established business continuity plans (BCPs) trying their best to secure that their production does not fall behind.

REPORT COVERAGE:

This research report on the global high-performance liquid chromatography market has been segmented and sub-segmented based on the products, instruments, consumables, applications, and region.

HPLC Market - By Product:

• Instruments
• Consumables
• Accessories

Based on the product, the instruments segment had the largest share in the global HPLC market in 2022 and is predicted to grow at a healthy CAGR during the forecast period. The growing demand for accurate and efficient analytical instruments for research, quality control, and drug development purposes primarily drives the growth of the instruments segment in the global market. The advancements in HPLC technology, such as improved detector sensitivity, higher resolution, faster analysis times, and enhanced automation boost the adoption of HPLC instruments and promote segmental growth. The growing applications of HPLC in various industries, including pharmaceuticals, biotechnology, food and beverages, environmental analysis, and forensic sciences contribute to the growth of the instruments segment in the global market.

The consumables segment is predicted to witness a promising CAGR during the forecast period owing to the growing demand for HPLC consumables, including columns, vials, filters, syringes, and solvents, among others. The growing number of HPLC tests conducted in laboratories, the increasing need for routine replacement of consumables and the rapid adoption of HPLC in various industries fuel the growth of the consumables segment in the worldwide market. An increasing number of advancements in consumable materials and designs, such as the development of high-performance stationary phases and column technologies supports the growth rate of the consumables segment.

HPLC Market - By Application:

• Clinical Research
• Diagnostics
• Forensics

Based on the application, the clinical research segment is predicted to account for the leading share of the global market during the forecast period. Factors such as the growing number of clinical trials, rising need for accurate and sensitive analysis of drugs and biomarkers in biological samples and increasing demand for reliable analytical methods to ensure drug safety and efficacy majorly drive the growth of the clinical research segment. The continuous advancements in HPLC technology, such as the development of new columns, detectors, and software contribute to the growth of the clinical research segment in the global HPLC market.

The diagnostics segment is expected to register a healthy CAGR during the forecast period owing to the growing prevalence of chronic diseases, increasing need for accurate and reliable diagnostic tests, and rising demand for personalized medicine. Technological advancements in HPLC, such as the integration of mass spectrometry and the development of high-throughput systems, contribute to the growth of the diagnostics segment in the worldwide market.

HPLC Market - By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• The Middle East and Africa

Geographically, the North American HPLC market had the largest share of the global market in 2022 and the domination of the North American region is expected to continue throughout the forecast period. The presence of advanced healthcare infrastructure, well-established pharmaceutical and biotechnology industries and a high emphasis on research and development in North America propels the growth of the North American HPLC market. The growing demand for high-quality and reliable analytical techniques in drug discovery and development, stringent regulatory requirements for quality control in pharmaceutical manufacturing and a strong focus on precision medicine and personalized healthcare further fuel the growth rate of the North American market. The U.S. held the major share of the North American market in 2022 and the lead of the U.S. is expected to continue throughout the forecast period owing to the presence of major players. The growing number of R&D investments in the U.S. majorly drives the U.S. market growth. The booming pharmaceutical industry in Canada is feeling the market. The US Food and Drug Administration's recommendations on chromatographic techniques to ensure proper identity, purity, and concentration of pharmaceuticals increase the use of high-performance liquid chromatography techniques. The government's policies and funding are boosting the market growth.

The European HPLC market had the second-largest share of the global market in 2022 and is expected to grow at a healthy CAGR during the forecast period. The growing investments by the key market participants in the pharmaceutical and biotechnology industry, and increasing demand for the LC-MS technique drive the European market growth. The strong pharmaceutical and biotechnology sectors, well-developed healthcare infrastructure and increasing demand for advanced analytical techniques fuel the growth rate of the European market. The growing investments in research and development activities, rising emphasis on quality control and regulatory compliance in pharmaceutical manufacturing, and the presence of leading pharmaceutical companies and academic institutions further favor the growth rate of the European market. The United Kingdom, Germany and Russia are projected to occupy the major share of the European market during the forecast period.

The HPLC market in Asia-pacific is expected to showcase the highest CAGR among all the regions in the worldwide market during the forecast period. Factors such as the rising emphasis on R&D and growing awareness about HPLC techniques boost the APAC market growth. The growing pharmaceutical and biotechnology industries, increasing research and development activities and rising healthcare expenditure propel the APAC market growth. The rising demand for advanced healthcare services, increasing focus on quality control and regulatory compliance in pharmaceutical manufacturing and the presence of a large patient pool requiring advanced diagnostic and therapeutic solutions further drive the HPLC market growth in the Asia-Pacific region. China led the market in the Asia-Pacific region in 2022, followed by India.

The Latin America HPLC market is anticipated to grow steadily during the forecast period owing to the presence of emerging economies and the growing R&D efforts by the market participants. The growing number of improvements in the healthcare infrastructure across the Latin American region, increasing investments in pharmaceutical research and development and rapid adoption of advanced analytical techniques propel the Latin American market growth. The growing prevalence of chronic diseases, increasing demand for quality pharmaceutical products, and government initiatives to enhance healthcare infrastructure and promote research and development drive the HPLC market in the Latin American region. Brazil followed by Mexico are estimated to hold the major share of the Latin American market in the coming years.

The HPLC market in MEA is projected to grow at a moderate CAGR during the forecast period. The growing number of initiatives from the governments of Middle East and Africa to enhance healthcare services, rising healthcare expenditure and the increasing demand for advanced diagnostic and research tools in the region drive the growth of the HPLC market in MEA.

KEY MARKET PLAYERS:

A few of the noteworthy leading the global high-performance liquid chromatography market profiled in this report are Waters Corporation, Agilent Technologies, Shimadzu Corporation, Thermo Fisher Scientific Inc., GE Healthcare, PerkinElmer Inc., Bio-Rad Laboratories Inc., Gilson Inc., Phenomenex Inc., and JASCO Inc.